{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:57:41Z","timestamp":1789052261045,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-024-04413-w","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T11:48:15Z","timestamp":1735213695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic implications of increased and final quantitative flow ratios in patients treated with drug-coated balloons physiological evaluation after DCB in de novo lesions"],"prefix":"10.1186","volume":"24","author":[{"given":"Li","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yida","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianglong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"issue":"12","key":"4413_CR1","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","volume":"13","author":"RV Jeger","year":"2020","unstructured":"Jeger RV, Eccleshall S, Wan Ahmad WA, et al. Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group. JACC Cardiovasc Interventions. 2020;13(12):1391\u2013402. https:\/\/doi.org\/10.1016\/j.jcin.2020.02.043.","journal-title":"JACC Cardiovasc Interventions"},{"issue":"10150","key":"4413_CR2","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0140-6736(18)31719-7","volume":"392","author":"RV Jeger","year":"2018","unstructured":"Jeger RV, Farah A, Ohlow MA, et al. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet (London England). 2018;392(10150):849\u201356. https:\/\/doi.org\/10.1016\/s0140-6736(18)31719-7.","journal-title":"Lancet (London England)"},{"issue":"2","key":"4413_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87\u2013165. https:\/\/doi.org\/10.1093\/eurheartj\/ehy394.","journal-title":"Eur Heart J"},{"issue":"6","key":"4413_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jacc.2015.11.042","volume":"67","author":"NV Pothineni","year":"2016","unstructured":"Pothineni NV, Shah NN, Rochlani Y, et al. U.S. Trends in inpatient utilization of fractional flow reserve and percutaneous coronary intervention. J Am Coll Cardiol. 2016;67(6):732\u20133. https:\/\/doi.org\/10.1016\/j.jacc.2015.11.042.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"4413_CR5","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.jcin.2018.04.037","volume":"11","author":"M Tebaldi","year":"2018","unstructured":"Tebaldi M, Biscaglia S, Fineschi M, et al. Evolving routine standards in invasive hemodynamic assessment of coronary stenosis: the nationwide Italian SICI-GISE cross-sectional ERIS study. JACC Cardiovasc Interventions. 2018;11(15):1482\u201391. https:\/\/doi.org\/10.1016\/j.jcin.2018.04.037.","journal-title":"JACC Cardiovasc Interventions"},{"key":"4413_CR6","doi-asserted-by":"publisher","unstructured":"Meng PN, Liu B, Li LB et al. Cut-off values of lesion and vessel quantitative flow ratio in de novo coronary lesion post-drug-coated balloon therapy predicting vessel restenosis at mid-term follow-up. Chinese Med J. 2021;134(12):1450\u20131456. https:\/\/doi.org\/10.1097\/cm9.0000000000001577.","DOI":"10.1097\/cm9.0000000000001577"},{"issue":"20","key":"4413_CR7","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/j.jacc.2016.08.051","volume":"68","author":"R Kornowski","year":"2016","unstructured":"Kornowski R, Lavi I, Pellicano M, et al. Fractional flow reserve derived from routine coronary angiograms. J Am Coll Cardiol. 2016;68(20):2235\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2016.08.051.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"4413_CR8","doi-asserted-by":"publisher","first-page":"e009603","DOI":"10.1161\/jaha.118.009603","volume":"7","author":"J Westra","year":"2018","unstructured":"Westra J, Andersen BK, Campo G, et al. Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: the FAVOR II Europe-Japan study. J Am Heart Association. 2018;7(14):e009603. https:\/\/doi.org\/10.1161\/jaha.118.009603.","journal-title":"J Am Heart Association"},{"issue":"25","key":"4413_CR9","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1016\/j.jacc.2017.10.035","volume":"70","author":"B Xu","year":"2017","unstructured":"Xu B, Tu S, Qiao S, et al. Diagnostic accuracy of angiography-based quantitative flow ratio measurements for online assessment of coronary stenosis. J Am Coll Cardiol. 2017;70(25):3077\u201387. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.035.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"4413_CR10","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.jcin.2019.06.003","volume":"12","author":"S Biscaglia","year":"2019","unstructured":"Biscaglia S, Tebaldi M, Brugaletta S, et al. Prognostic value of QFR measured immediately after successful stent implantation: the international multicenter prospective HAWKEYE study. JACC Cardiovasc Interventions. 2019;12(20):2079\u201388. https:\/\/doi.org\/10.1016\/j.jcin.2019.06.003.","journal-title":"JACC Cardiovasc Interventions"},{"issue":"19","key":"4413_CR11","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.jcin.2016.07.013","volume":"9","author":"S Tu","year":"2016","unstructured":"Tu S, Westra J, Yang J, et al. Diagnostic accuracy of fast computational approaches to Derive Fractional Flow Reserve from Diagnostic Coronary Angiography: the International Multicenter FAVOR Pilot Study. JACC Cardiovasc Interv. 2016;9(19):2024\u201335. https:\/\/doi.org\/10.1016\/j.jcin.2016.07.013.","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"4413_CR12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ccd.28531","volume":"96","author":"A Erbay","year":"2020","unstructured":"Erbay A, Steiner J, Lauten A, et al. Assessment of intermediate coronary lesions by fractional flow reserve and quantitative flow ratio in patients with small-vessel disease. Catheter Cardiovasc Interv. 2020;96(4):743\u201351. https:\/\/doi.org\/10.1002\/ccd.28531.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"20","key":"4413_CR13","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.jcin.2018.07.031","volume":"11","author":"JM Lee","year":"2018","unstructured":"Lee JM, Hwang D, Choi KH, et al. Prognostic implications of relative increase and final fractional flow reserve in patients with stent implantation. JACC Cardiovasc Interventions. 2018;11(20):2099\u2013109. https:\/\/doi.org\/10.1016\/j.jcin.2018.07.031.","journal-title":"JACC Cardiovasc Interventions"},{"issue":"5","key":"4413_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0002-9149(91)90780-o","volume":"68","author":"MS Huber","year":"1991","unstructured":"Huber MS, Mooney JF, Madison J, et al. Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol. 1991;68(5):467\u201371. https:\/\/doi.org\/10.1016\/0002-9149(91)90780-o.","journal-title":"Am J Cardiol"},{"issue":"17","key":"4413_CR15","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/circulationaha.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344\u201351. https:\/\/doi.org\/10.1161\/circulationaha.106.685313.","journal-title":"Circulation"},{"issue":"16","key":"4413_CR16","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","volume":"126","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020\u201335. https:\/\/doi.org\/10.1161\/CIR.0b013e31826e1058.","journal-title":"Circulation"},{"issue":"11","key":"4413_CR17","doi-asserted-by":"publisher","first-page":"e024903","DOI":"10.1161\/jaha.121.024903","volume":"11","author":"N Dai","year":"2022","unstructured":"Dai N, Yuan S, Dou K, et al. Prognostic implications of prestent pullback pressure gradient and poststent quantitative flow ratio in patients undergoing percutaneous coronary intervention. J Am Heart Association. 2022;11(11):e024903. https:\/\/doi.org\/10.1161\/jaha.121.024903.","journal-title":"J Am Heart Association"},{"issue":"10261","key":"4413_CR18","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/s0140-6736(20)32173-5","volume":"396","author":"RV Jeger","year":"2020","unstructured":"Jeger RV, Farah A, Ohlow MA, et al. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Lancet (London England). 2020;396(10261):1504\u201310. https:\/\/doi.org\/10.1016\/s0140-6736(20)32173-5.","journal-title":"Lancet (London England)"},{"key":"4413_CR19","doi-asserted-by":"publisher","unstructured":"Tang Y, Qiao S, Su X et al. Drug-coated balloon versus drug-eluting stent for small-vessel disease: the RESTORE SVD China randomized trial. JACC Cardiovascular Interv. 2018;11(23):2381\u201392 https:\/\/doi.org\/10.1016\/j.jcin.2018.09.009","DOI":"10.1016\/j.jcin.2018.09.009"},{"issue":"10317","key":"4413_CR20","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/s0140-6736(21)02248-0","volume":"398","author":"B Xu","year":"2021","unstructured":"Xu B, Tu S, Song L, et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet (London England). 2021;398(10317):2149\u201359. https:\/\/doi.org\/10.1016\/s0140-6736(21)02248-0.","journal-title":"Lancet (London England)"},{"key":"4413_CR21","doi-asserted-by":"publisher","unstructured":"Kern MJ, Seto AH. Comparing QFR and FFR in small vessels-expanding the spectrum of use. Catheter Cardiovasc Interv. 2020;96(4):752\u20134. https:\/\/doi.org\/10.1002\/ccd.29297.","DOI":"10.1002\/ccd.29297"},{"key":"4413_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijcard.2020.11.035","volume":"327","author":"L Li","year":"2021","unstructured":"Li L, Guan C, Meng S, et al. Short- and long-term functional results following drug-coated balloons versus drug- eluting stents in small coronary vessels: the RESTORE quantitative flow ratio study. Int J Cardiol. 2021;327:45\u201351. https:\/\/doi.org\/10.1016\/j.ijcard.2020.11.035.","journal-title":"Int J Cardiol"},{"issue":"17","key":"4413_CR23","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.jcin.2021.07.014","volume":"14","author":"SH Lee","year":"2021","unstructured":"Lee SH, Kim J, Lefieux A, et al. Clinical and prognostic impact from objective analysis of post-angioplasty fractional flow reserve pullback. JACC Cardiovasc Interventions. 2021;14(17):1888\u2013900. https:\/\/doi.org\/10.1016\/j.jcin.2021.07.014.","journal-title":"JACC Cardiovasc Interventions"},{"issue":"21","key":"4413_CR24","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/j.jcin.2022.08.036","volume":"15","author":"BF Uretsky","year":"2022","unstructured":"Uretsky BF, Agarwal SK, Vallurupalli S, et al. Trans-Stent FFR Gradient as a modifiable integrant in Predicting Long-Term Target Vessel failure. JACC: Cardiovasc Interventions. 2022;15(21):2192\u2013202. https:\/\/doi.org\/10.1016\/j.jcin.2022.08.036.","journal-title":"JACC: Cardiovasc Interventions"},{"issue":"24","key":"4413_CR25","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","volume":"13","author":"B Cortese","year":"2020","unstructured":"Cortese B, Di Palma G, Guimaraes MG, et al. Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial. JACC Cardiovasc Interventions. 2020;13(24):2840\u20139. https:\/\/doi.org\/10.1016\/j.jcin.2020.08.035.","journal-title":"JACC Cardiovasc Interventions"},{"key":"4413_CR26","doi-asserted-by":"publisher","first-page":"935263","DOI":"10.3389\/fcvm.2022.935263","volume":"9","author":"X Yang","year":"2022","unstructured":"Yang X, Lu W, Pan L, et al. Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions. Front Cardiovasc Med. 2022;9:935263. https:\/\/doi.org\/10.3389\/fcvm.2022.935263.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"4413_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00392-014-0775-2","volume":"104","author":"FX Kleber","year":"2015","unstructured":"Kleber FX, Schulz A, Waliszewski M, et al. Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty. Clin Res Cardiology: Official J German Cardiac Soc. 2015;104(3):217\u201325. https:\/\/doi.org\/10.1007\/s00392-014-0775-2.","journal-title":"Clin Res Cardiology: Official J German Cardiac Soc"},{"issue":"10","key":"4413_CR28","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s00392-017-1126-x","volume":"106","author":"A Funatsu","year":"2017","unstructured":"Funatsu A, Nakamura S, Inoue N, et al. A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients with small vessel disease. Clin Res Cardiology: Official J German Cardiac Soc. 2017;106(10):824\u201332. https:\/\/doi.org\/10.1007\/s00392-017-1126-x.","journal-title":"Clin Res Cardiology: Official J German Cardiac Soc"},{"issue":"4","key":"4413_CR29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/ccd.30598","volume":"101","author":"K Ueno","year":"2023","unstructured":"Ueno K, Morita N, Kojima Y, et al. Serial quantitative angiographic study of target lumen enlargement after drug-coated balloon angioplasty for native coronary artery disease. Catheter Cardiovasc Interv. 2023;101(4):713\u201321. https:\/\/doi.org\/10.1002\/ccd.30598.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"4413_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jcin.2020.10.055","volume":"14","author":"S Biscaglia","year":"2021","unstructured":"Biscaglia S, Uretsky B, Barbato E, et al. Invasive coronary physiology after stent implantation: another step toward precision medicine. JACC Cardiovasc Interventions. 2021;14(3):237\u201346. https:\/\/doi.org\/10.1016\/j.jcin.2020.10.055.","journal-title":"JACC Cardiovasc Interventions"},{"issue":"7","key":"4413_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jcin.2022.10.054","volume":"16","author":"S Biscaglia","year":"2023","unstructured":"Biscaglia S, Verardi FM, Tebaldi M, et al. QFR-based virtual PCI or conventional angiography to guide PCI: the AQVA trial. JACC Cardiovasc Interventions. 2023;16(7):783\u201394. https:\/\/doi.org\/10.1016\/j.jcin.2022.10.054.","journal-title":"JACC Cardiovasc Interventions"},{"key":"4413_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijcard.2022.01.054","volume":"352","author":"R Zhang","year":"2022","unstructured":"Zhang R, Xu B, Dou K, et al. Post-PCI outcomes predicted by pre-intervention simulation of residual quantitative flow ratio using augmented reality. Int J Cardiol. 2022;352:33\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2022.01.054.","journal-title":"Int J Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04413-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04413-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04413-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T12:02:55Z","timestamp":1735214575000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04413-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4413"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04413-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committee of Beijing Anzhen hospital and informed consent was provided by all of the patients according to hospital guidelines. All the experiment was conducted according to the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"743"}}